Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Structural Modification. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN104098511A reveals a novel acetylation method converting N-deacetyllappaconitine byproducts into high-purity lappaconitine, offering significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN103626828A details novel ursolic acid modifications enhancing antitumor activity. This report analyzes scalable synthesis routes for reliable pharmaceutical intermediate supply chains.
Patent CN103232467B reveals novel Sinomenine modifications offering superior anti-inflammatory activity and scalable synthesis for global pharmaceutical supply chains.
Novel Morusin derivatives synthesis via total synthesis route. Offers cost reduction in pharmaceutical intermediate manufacturing and high-purity supply for oncology research.